Intravenous (IV) and subcutaneous (SC) formulations each play important roles in modern oncology care, with distinct ...
The U.S. Food and Drug Administration has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and ...
The Chosun Ilbo on MSN
Jun Hyun-moo's agency reveals medical records to refute IV drip claims
Broadcaster Jun Hyun-moo’s agency addressed allegations of an “illegal in-vehicle IV drip” by publicly releasing medical records from the time, reiterating its explanation. SM C&C, Jun Hyun-moo’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback